PubRank

Yasser Khazaal

Author PubWeight™ 27.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Khat use: lifestyle or addiction? J Psychoactive Drugs 2009 1.05
2 Motivations to play specifically predict excessive involvement in massively multiplayer online role-playing games: evidence from an online survey. Eur Addict Res 2011 1.00
3 Psychological predictors of problematic involvement in massively multiplayer online role-playing games: illustration in a sample of male cybercafé players. Psychopathology 2011 0.97
4 Quality of web-based information on bipolar disorder. J Affect Disord 2008 0.94
5 Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin. Subst Abus 2004 0.94
6 Validation of a short French version of the UPPS-P Impulsive Behavior Scale. Compr Psychiatry 2011 0.92
7 Quality of Web-based information on depression. Depress Anxiety 2010 0.90
8 Lack of inhibitory control predicts cigarette smoking dependence: evidence from a non-deprived sample of light to moderate smokers. Drug Alcohol Depend 2010 0.88
9 Trait gambling cognitions predict near-miss experiences and persistence in laboratory slot machine gambling. Br J Psychol 2011 0.88
10 Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today (Barc) 2004 0.87
11 The relationship between addiction and religion and its possible implication for care. Subst Use Misuse 2010 0.85
12 The Beck Cognitive Insight Scale in outpatients with psychotic disorders: further evidence from a French-speaking sample. Can J Psychiatry 2008 0.84
13 Validation of the French version of the alcohol, smoking and substance involvement screening test (ASSIST). Eur Addict Res 2011 0.84
14 A follow-up study on the quality of alcohol dependence-related information on the web. Subst Abuse Treat Prev Policy 2011 0.83
15 Mirtazapine in drug-induced excessive sweating. Eur J Clin Pharmacol 2005 0.81
16 Psychopharmacological treatment in pathological gambling: a critical review. Curr Pharm Des 2011 0.81
17 Quality of Web-based information on obsessive compulsive disorder. Neuropsychiatr Dis Treat 2013 0.81
18 [Assessing the quality of French language web sites pertaining to alcohol dependency]. Sante Ment Que 2008 0.80
19 Does the form or the amount of exposure make a difference in the cognitive-behavioral therapy treatment of social phobia? J Nerv Ment Dis 2009 0.80
20 Validation of the French version of the alcohol, smoking and substance involvement screening test (ASSIST) in the elderly. Subst Abuse Treat Prev Policy 2012 0.79
21 Local back massage with an automated massage chair: general muscle and psychophysiologic relaxing properties. J Altern Complement Med 2005 0.79
22 Alcohol-related brief intervention in patients treated for opiate or cocaine dependence: a randomized controlled study. Subst Abuse Treat Prev Policy 2011 0.79
23 Impact of psychiatrists' qualifications on the rate of compulsory admissions. Psychiatr Q 2013 0.78
24 Cannabis and psychosis. Lancet 2007 0.78
25 Naltrexone-assisted rapid methadone discontinuation: a pilot study. Eur Addict Res 2007 0.77
26 Swiss psychiatrists' beliefs and attitudes about internet addiction. Psychiatr Q 2009 0.77
27 Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes. Eur J Clin Pharmacol 2007 0.77
28 The Geneva Appetitive Alcohol Pictures (GAAP): development and preliminary validation. Eur Addict Res 2011 0.77
29 Cannabis and the course of schizophrenia. Am J Psychiatry 2008 0.76
30 The potential interest of topiramate in addiction. Curr Pharm Des 2011 0.76
31 Improvement of cognitive performance by topiramate: Blockage of automatic processes may be the underlying mechanism. Prog Neuropsychopharmacol Biol Psychiatry 2007 0.76
32 Topiramate for smoking cessation and the importance to distinguish withdrawal-motivated consumption and cue-triggered automatisms. J Clin Psychopharmacol 2009 0.75
33 Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions. Br J Clin Pharmacol 2005 0.75
34 [The quality of Internet medical sites]. Rev Med Suisse 2007 0.75
35 [Addiction]. Rev Med Suisse 2015 0.75
36 Swiss psychiatrists beliefs and attitudes about cannabis risks in psychiatric patients: ideologically determined or evidence-based? Community Ment Health J 2007 0.75
37 Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder. Ann Pharmacother 2007 0.75
38 The "rut metaphor": a conceptualization of attractor-shaping properties of addictive drugs. Subst Use Misuse 2008 0.75
39 Understanding Swiss drug policy change and the introduction of heroin maintenance treatment. Eur Addict Res 2014 0.75
40 Escitalopram/reboxetine combination in depressed patients with substance use disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004 0.75
41 Pornographic effect of olanzapine: induction of vivid intrusive sexual obsessional images. Gen Hosp Psychiatry 2006 0.75
42 Obsessive-compulsive symptoms precipitated by methadone tapering. J Clin Psychopharmacol 2004 0.75
43 Tragic logic or how evidence does not change convictions: the perception of Geneva's addictology caregivers concerning the utility of disulfiram. J Addict Nurs 2012 0.75
44 [Pharmacotherapy of anxiety in the addicted patient]. Rev Med Suisse Romande 2004 0.75
45 Venlafaxine versus applied relaxation for generalized anxiety disorder: a randomized controlled study on clinical and electrophysiological outcomes. Psychiatr Q 2015 0.75
46 Quality of Smartphone Apps Related to Alcohol Use Disorder. Eur Addict Res 2016 0.75
47 [How hypervigilance and hyperreactivity clinically described in anxiety expressed physiologically?]. Sante Ment Que 2004 0.75